“The CDSCO (Central Drugs Standard Control Organisation) has approved a vital randomised controlled trial on Covid-19 treatment with a biological called tocilizumab, in the first proposed multi-centre trial with the drug in India,” said Dr AS Soin, national lead investigator for the trial.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2ST9Dmf
via IFTTT
0 comments:
Post a Comment